Scientists Aim to Mutate Avian Flu in Lab to Better Understand its Spread

Diane Barnes, Global Security Newswire
Aug. 8, 2013, 12:02 p.m.

WASH­ING­TON — Nearly two dozen vir­o­lo­gists from around the world on Wed­nes­day said they want to modi­fy an emer­ging form of avi­an in­flu­enza in ways that could pro­duce more con­ta­gious, vir­u­lent or drug-res­ist­ant forms of the dis­ease.

The stud­ies would aim to shed light on how the so-called H7N9 vir­us could threaten hu­mans as it mutates in nature, the 22 re­search­ers wrote in a let­ter pub­lished in the journ­als Sci­ence and Nature. Their an­nounce­ment came one day after sci­ent­ists said a Chinese wo­man ap­peared to have caught the vir­us dir­ectly from her fath­er, ul­ti­mately killing both in what might be first case of the germ leap­ing dir­ectly between hu­mans.

The vir­us as of late May had spread to 132 people, 37 of whom had died as a res­ult, ac­cord­ing to the World Health Or­gan­iz­a­tion. China re­por­ted H7N9’s ini­tial jump to a hu­man at the end of March, but that case and those to fol­low ap­peared to be in­stances of trans­mis­sion from in­fec­ted birds.

When dis­eases mutate and take on new cap­ab­il­it­ies — such as the emer­ging trans­mis­sion of avi­an flu from one hu­man to an­oth­er — sci­ent­ists typ­ic­ally seek to study that muta­tion’s “gain of func­tion.” Such ana­lyses aim to de­vel­op a fuller un­der­stand­ing of the muta­tion as a first step to­ward fight­ing it.

“The risk of a pan­dem­ic caused by an avi­an in­flu­enza vir­us ex­ists in nature,” the sci­ent­ists wrote this week. “To an­swer key ques­tions im­port­ant to pub­lic health, re­search that may res­ult in [gain of func­tion] is ne­ces­sary and should be done.”

The pro­pos­al has already pro­voked ques­tions from ex­perts doubt­ful that any sci­entif­ic be­ne­fits from such ex­per­i­ments would out­weigh the risk of a mod­i­fied vir­us es­cap­ing — or be­ing stolen — from a labor­at­ory.

In an in­ter­view with Sci­ence, Prin­ceton Uni­versity mo­lecu­lar bio­lo­gist Ad­el Mah­moud said the pro­pos­al’s sci­entif­ic ra­tionale “is very flimsy, to put it mildly.” He ad­ded: “The claims that it will lead to any­thing use­ful are light­weight.”

In an at­tempt to ad­dress safety and se­cur­ity con­cerns, the let­ter’s au­thors ar­gued that safe­guards and pre­par­a­tion for the new stud­ies have been sig­ni­fic­antly in­formed by earli­er de­bate over gain-of-func­tion stud­ies in­volving an older avi­an flu sub­type, dubbed H5N1. Earli­er this year, flu re­search­ers ended a one-year vol­un­tary morator­i­um on the modi­fic­a­tion of that vir­us, which has been cir­cu­lat­ing among hu­mans since 2003 in a hard-to-catch but highly vir­u­lent form.

“The World Health Or­gan­iz­a­tion is­sued labor­at­ory biosafety guidelines for con­duct­ing re­search on H5N1 trans­mis­sion and, in the United States, ad­di­tion­al over­sight policies and risk-mit­ig­a­tion prac­tices have been put in place or pro­posed,” the Wed­nes­day let­ter states.

Stud­ies should take place un­der strin­gent “Biosafety Level 3 en­hanced” con­di­tions, in­volving safe­guards used in hand­ling po­ten­tially leth­al dis­eases, the re­search­ers said in an ac­com­pa­ny­ing doc­u­ment. Per­son­nel should un­der­go “rel­ev­ant back­ground checks” be­fore be­ing cleared to work with mod­i­fied agent, they said.

Re­search in­sti­tu­tions seek­ing U.S. funds to carry out cer­tain kinds of changes to the vir­us would see their grant re­quests un­der­go spe­cial re­view, Health and Hu­man Ser­vices De­part­ment of­fi­cials said in a state­ment made pub­lic on Wed­nes­day. However, the as­sur­ances of ad­di­tion­al scru­tiny ap­plied solely to pro­posed ex­per­i­ments deemed likely to in­crease the agent’s air­borne trans­miss­ib­il­ity.

A Chinese study has re­vealed an H7N9 vir­us strain already cap­able of passing through the air between fer­rets, a mam­mal of­ten used as a mod­el for hu­man trans­mis­sion.

H7N9 pro­duces its most severe hu­man symp­toms after tak­ing root in the lungs, but vir­us particles can also cause loc­al­ized in­fec­tions on “any mu­cous mem­brane,” in­clud­ing in the mouth, eyes and up­per res­pir­at­ory tract, said Amesh Adalja, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter.

The agent can­not spread ef­fect­ively through the di­gest­ive sys­tem, Adalja ad­ded by tele­phone on Thursday.

The pause in H5N1 re­search took ef­fect after a U.S. bi­o­se­c­ur­ity pan­el aired wor­ries that find­ings from such re­search could po­ten­tially help bad act­ors en­gin­eer an en­hanced vir­us for an act of bi­o­ter­ror­ism.

However, de­bate dur­ing the morator­i­um “fo­cused over­whelm­ingly on the risks of ac­ci­dent­al re­lease of mod­i­fied mi­crobes,” ac­cord­ing to Der­rin Culp, a re­search as­so­ci­ate at Columbia Uni­versity’s Na­tion­al Cen­ter for Dis­aster Pre­pared­ness.

Bi­o­ter­ror­ism came up only “oc­ca­sion­ally” in dis­cus­sions among of­fi­cials and re­search­ers, and at no point was there any high-pro­file look at “the risk of de­lib­er­ate re­lease by an in­sider,” he wrote in April’s edi­tion of the Bul­let­in of the Atom­ic Sci­ent­ists.

Of­fi­cials and in­de­pend­ent ex­perts have gen­er­ally ad­vised giv­ing labor­at­ory man­agers con­sid­er­able free­dom in how they de­cide whom to en­trust with high-risk patho­gens. The ap­proach, he wrote, “would be deemed … naïve and ut­terly in­ad­equate” had more people died as a res­ult of the 2001 an­thrax at­tacks con­tro­ver­sially blamed on a U.S. Army mi­cro­bi­o­lo­gist.

Without ad­dress­ing wheth­er flu-modi­fic­a­tion ex­per­i­ments should be con­tin­ued, Culp said fed­er­al and state le­gis­lat­ors could al­ter pri­vacy stat­utes to “per­mit more in­trus­ive screen­ing and mon­it­or­ing” of in­di­vidu­als who handle dan­ger­ous bio­lo­gic­al agents. Such over­sight might be com­par­able to meas­ures fo­cused on people who work with nuc­le­ar weapons and re­lated ma­ter­i­als, he wrote.

“Mi­cro­bi­o­lo­gists can’t be ex­empt from such scru­tiny,” Culp said. “They lost that priv­ilege when they ac­quired the abil­ity — or merely the po­ten­tial — to gen­er­ate mass cas­u­al­ties.”

What We're Following See More »
Trump Won’t Debate Sanders After All
1 days ago

Trump, in a statement: “Based on the fact that the Democratic nominating process is totally rigged and Crooked Hillary Clinton and Deborah Wasserman Schultz will not allow Bernie Sanders to win, and now that I am the presumptive Republican nominee, it seems inappropriate that I would debate the second place finisher. ... I will wait to debate the first place finisher in the Democratic Party, probably Crooked Hillary Clinton, or whoever it may be.”

UAW: Time to Unite Behind Hillary
2 days ago

"It's about time for unity," said UAW President Dennis Williams. "We're endorsing Hillary Clinton. She's gotten 3 million more votes than Bernie, a million more votes than Donald Trump. She's our nominee." He called Sanders "a great friend of the UAW" while saying Trump "does not support the economic security of UAW families." Some 28 percent of UAW members indicated their support for Trump in an internal survey.

Trump Clinches Enough Delegates for the Nomination
2 days ago

"Donald Trump on Thursday reached the number of delegates needed to clinch the Republican nomination for president, completing an unlikely rise that has upended the political landscape and sets the stage for a bitter fall campaign. Trump was put over the top in the Associated Press delegate count by a small number of the party's unbound delegates who told the AP they would support him at the convention."

Trump/Sanders Debate Before California Primary?
2 days ago
California: It’s Not Over Yet
2 days ago

"Clinton and Bernie Sanders "are now devoting additional money to television advertising. A day after Sanders announced a new ad buy of less than $2 million in the state, Clinton announced her own television campaign. Ads featuring actor Morgan Freeman as well as labor leader and civil rights activist Dolores Huerta will air beginning on Fridayin Fresno, Sacramento, and Los Angeles media markets. Some ads will also target Latino voters and Asian American voters. The total value of the buy is about six figures according to the Clinton campaign." Meanwhile, a new poll shows Sanders within the margin of error, trailing Clinton 44%-46%.